Central Islip, NY, United States
Ascent Pharmaceuticals, Inc. recalls
3 recalls recorded since 2018, most recently on 19 November 2021. None are listed as ongoing. Status and classification are as published by the FDA.
Recalls3
Ongoing (FDA)0
Terminated or completed3
Class I (FDA)0
Terminated Class II Drugs
- Recall started
- 19 November 2021
- Terminated
- 6 December 2023
- Reason
- Product Mix-up
- Distribution
- USA Nationwide
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-0276-2022
- Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/325 mg, 100-count bottle, Rx only, Manufactured for: Camber Pharmaceuticals, Inc. Piscataway, NJ 08854, Manufactured by: Ascent Pharmaceuticals, Inc., Central I
Terminated Class II Drugs
- Recall started
- 26 October 2020
- Terminated
- 17 February 2023
- Reason
- Presence of Foreign Tablet/Capsule: One bottle of Hydrocodone Bitartrate and Acetaminophen Tablets USP 10mg/325 mg contains one Losartan Potassium Tablets, USP 100 mg.
- Distribution
- Nationwide within the United States
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-0097-2021
- Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/325mg 100-count bottles, Rx Only, Manufactured for : Camber Pharmaceuticals, Inc. Piscataway, NJ 08854, Manufactured by: Ascent Pharmaceuticals, Inc. Central Is
Terminated Class III Drugs
- Recall started
- 22 January 2018
- Terminated
- 23 April 2018
- Reason
- Labeling; Label Error Not Elsewhere Classified; label missing controlled substance CII symbol
- Distribution
- Nationwide
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-0248-2018
- Oxycodone Hydrochloride Tablets, USP 15 mg, 100 count bottles, Rx only, Manufactured for Camber Pharmaceuticals, Inc., Piscataway, NJ, Manufactured by: Ascent Pharmaceuticals, Inc., Central Islip, NY --- NDC 31722-917-01
A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.